2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Bepirovirsen: new trials by email Literature Review of Bepirovirsen trials Research Report on Bepirovirsen
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 1) Bepirovirsen, Placebo - Chronic Hepatitis B, Hepatitis B, Chronic | Phase 3 | Completed | GlaxoSmithKline | 981 | 2022-12-07 | 2026-07-08 |
| Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 2) Bepirovirsen, Placebo - Chronic Hepatitis B, Hepatitis B, Chronic | Phase 3 | Completed | GlaxoSmithKline | 857 | 2022-12-06 | 2026-07-08 |
Hepatitis (2) · Hepatitis B (2) · Hepatitis B, Chronic (2) · Hepatitis, Chronic (2)
GlaxoSmithKline (2)
Argentina (2) · Brazil (2) · Bulgaria (2) · Canada (2) · China (2) · France (2) · Germany (2) · Greece (2) · Hungary (2) · India (2) · Italy (2) · Japan (2) · Malaysia (2) · Mexico (2) · Panama (2)